News Startups Venture Capital PharmEasy’s ₹3,500 crore rights issue oversubscribed, co-founder Siddharth Shah to have 3-year lock-in for remaining stake Fresh details are emerging from PharmEasy’s much sought after rights issue. The… Soumyadeep SarkarNovember 1, 20232 minute read
News Startups PharmEasy shelves IPO plans, opts for a rights issue instead An ambitious attempt by several of India’s high profile tech unicorns to… Soumyadeep SarkarAugust 22, 20222 minute read